The data of cell counting and MTS assays presented that the NME2 knockout (KO) resulted in a significant decrease of the number and cell viability of gastric cancer stem-like cells, while the cell number and viability of the cells with NME2 rescue treatment were comparable to those of NME2 wild-type (WT) cells (Fig. 3e, f). This evidence concerns the gene NME2 and gastric cancer.